Maghemite functionalization for antitumor drug vehiculization

Molecular Pharmaceutics

Volumn 9, Issue 7, 2012, Pages 2017-2028

  Rudzka, Katarzyna ^a   Delgado, Ángel V ^a   Viota, Julián L ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

Author keywords

doxorubicin; gold shell; maghemite; magnetic resonance imaging; nanostructures; silica coating; superparamagnetism; targeted drug delivery

Indexed keywords

CONTRAST MEDIUM; DOXORUBICIN; FERRIC OXIDE; NANOCOMPOSITE; SILICON DIOXIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CANCER CHEMOTHERAPY; COLON ADENOCARCINOMA; CONTROLLED DRUG RELEASE; DRUG BINDING AND TRANSPORT; DRUG DELIVERY SYSTEM; FOLLOW UP; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPERATURE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETICS; NANOCOMPOSITES; NANOPARTICLES; NANOSTRUCTURES; SILICON DIOXIDE;

EID: 84863320491     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp3002705     Document Type: Article

References (90)

1. World Health Organization. World Cancer Report; Steward, B. W., Kleihues, P., Eds.; The International Agency for Research on Cancer: Lyon, France, 2003.
2. Rozanowska, N.; Zhang, J. Z. Photothermal ablation therapy for cancer based on metal nanostructures Sci. China Ser. B: Chem. 2009, 52 (10) 1559-1575
3. Melancon, M. P.; Lu, W.; Li, Ch. Gold-Based Magneto/Optical Nanostructures: Challenges for In Vivo Applications in Cancer Diagnostics and Therapy MRS Bull. 2009, 34, 415-421
4. Davis, M. E.; Chen, Z.; Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
5. Sanvicens, N.; Marco, M. P. Multifunctional nanoparticles - properties and prospects for their use in human medicine Trends Biotechnol. 2008, 26, 425-433
6. Hernandez, J. F.; Secrest, J. A.; Hill, L.; McClarty, J. S. Scientific Advances in the Genetic Understanding and Diagnosis of Malignant Hyperthermia J. Perianesth. Nurs. 2009, 24, 19-34
7. Peller, M.; Kurze, V.; Loeffler, R.; Pahernik, S.; Dellian, M. Hyperthermia induces T1 relaxation and blood flow changes in tumors. A MRI thermometry study in vivo Magn. Reson. Imaging 2003, 21, 545-551
8. Hildebrandt, B.; Wurst, P.; Ahlers, O.; Dieing, A.; Screenivasa, G.; Kerner, T. The cellular and molecular basis of hyperthermia Crit. Rev. Oncol./Hematol. 2002, 43, 33-56
9. 2+: A possible maneuver for spermicidal activity Drug Dev. Res. 2005, 65, 1-16
10. Dewey, W. C.; Hopwood, L. E.; Sapareto, S. A.; Gerweck, L. E. Cellular Responses to Combinations of Hyperthermia and Radiation Radiology 1977, 123, 463-474
11. Barry, M. A.; Behnkea, C. A.; Eastman, A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia Biochem. Pharmacol. 1990, 40, 2353-2362
12. Kong, G.; Braun, R. D.; Dewhirst, M. W. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size Cancer Res. 2000, 60, 4440-4445
13. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Controlled Release 2000, 65, 271-284
14. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 2001, 41, 189-207
15. Klug, G.; Kampf, T.; Bloemer, S.; Bremicker, J.; Ziener, Ch. H.; Heymer, A.; Gbureck, U.; Rommel, E.; Nöth, U.W. A.; Schenk, J.; Bauer, W. R. Intracellular and extracellular T1 and T2 relaxivities of magneto-optical nanoparticles at experimental high fields Magn. Reson. Med. 2010, 64, 1607-1615
16. 1 Magnetic Resonance Imaging Contrast Agents for Molecular Imaging Langmuir 2007, 23, 4583-4588
17. Billotey, C.; Wilhelm, C.; Devaud, M.; Bacri, J. C.; Bittoun, J.; Gazeau, F. Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging Magn. Reson. Med. 2003, 49, 646-654
18. Nawara, K.; Romiszewski, J.; Kijewska, K.; Szczytko, J.; Twardowski, A.; Mazur, M.; Krysinski, P. Adsorption of doxorubicin onto citrate-stabilized magnetic nanoparticles J. Phys. Chem. C 2012, 116, 5598-5609
19. Sajja, H. K.; Eest, M. P.; Mao, H.; Wang, Y. A.; Nie, S. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect Curr. Drug Discovery Technol. 2009, 6 (1) 43-51
20. Torchilin, V. P. Targeted Pharmaceutical Nanocarriers for Cancer Therapy and Imaging. AAPS J. 2007, 9 (2), Article 15.
21. Müller, R. H. Colloidal Carriers for Controlled Drug Delivery and Targeting - Modification, Characterization and in vivo Distribution; Wissenschaftliche Verlagsgesellschaft Stuttgart, CRC Press: Boca Raton, 1991; p 379.
22. Munnier, E.; Cohen-Jonathan, S.; Linassier, C.; Douziech-Eyrolles, L.; Marchais, H.; Soucé, M.; Hervé, K.; Dubois, P.; Chorupa, I. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting Int. J. Pharm. 2008, 363, 170-176
23. Colombo, M.; Carregal-Romero, S.; Casula, M. F.; Gutiérrez, L.; Morales, M. P.; Böhm, I. B.; Heverhagen, J. T.; Prosperi, D.; Parak, W. J. Biological applications of magnetic nanoparticles Chem. Soc. Rev. 2012, 41, 4306-4334 10.1039/c2cs15337h
24. Zhou, L.; Yuan, J.; Wei, Y. Core-shell structural iron oxide hybrid nanoparticles: from controlled synthesis to biomedical applications J. Mater. Chem. 2011, 21, 2823-2840
25. Chomoucka, J.; Drbohlavova, J.; Huska, D.; Adam, V.; Kizek, R.; Hubalek, J. Magnetic nanoparticles and targeted drug delivering Pharmacol. Res. 2010, 62, 144-149
26. El-Dakdouki, M. H.; Zhu, D. C.; El-Boubbou, K.; Kamat, M.; Chen, J.; Li, W.; Huang, X. Development of multifuncional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells Biomacromolecules 2012, 13, 1144-1151
27. Alexiou, C.; Jurgons, R. In Magnetism in medicine: a handbook; Andrä, W.; Nowak, H., Eds.; Wiley-VCH: Berlin, 2007; p 596.
28. Hainfeld, J.; Slatkin, D.; Smilowitz, H. The use of gold nanoparticles to enhance radiotherapy in mice Phys. Med. Biol. 2004, 49, N309-N315
29. Paciotti, G. F.; Myer, L.; Weinreich, D.; Goia, D.; Pavel, N.; McLaughlin, R. E.; Tamarkin, L. Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery Drug Delivery 2004, 11, 169-183
30. Brown, C. L.; Bushel, G.; Whitehouse, M. W.; Agrawal, D. S.; Tupe, S. G.; Paknikar, K. M.; Tiekink, E. R. T. Nanogoldpharmaceutics: (i) The use of colloidal gold to treat experimentally-induced arthritis in rat models; (ii) Characterization of the gold in Swarna bhasma, a microparticulate used in traditional Indian medicine Gold Bull. 2007, 40/3, 245-250
31. Kumar, S. A.; Peter, Y.-A.; Nadeau, J. L. Facile biosynthesis, separation and conjugation of gold nanoparticles to doxorubicin Nanotechnology 2008, 19, 495101, 10 pp
32. Cheng, Y.; Samia, A. C.; Li, J.; Kenney, M. E.; Resnick, A.; Burda, C. Delivery and Efficacy of a Cancer Drug as a Function of the Bond to the Gold Nanoparticle Surface Langmuir 2010, 26, 2248-2255
33. López-Viota, J.; Delgado, A. V.; Toca-Herrera, J. L.; Möller, M.; Zanuttin, F.; Balestrino, M.; Krol, S. Electrophoretic characterization of gold nanoparticles functionalized with human serum albumin (HSA) and creatine J. Colloid Interface Sci. 2009, 332, 215-23
34. Lee, N.; Hyeon, T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents Chem. Soc. Rev. 2012, 41, 2575-2589
35. Mukherjee, P.; Bhattacharya, R.; Wang, P.; Wang, L.; Basu, S.; Nagy, J. A.; Atala, A.; Mukhopadhyay, D.; Soker, S. Antiangiogenic properties of gold nanoparticles Clin. Cancer Res. 2005, 11, 3530-3534
36. You, J.; Zhang, G.; Li, Ch. Exceptionally High Payload of Doxorubicin in Hollow Gold Nanospheres for Near-Infrared Light-Triggered Drug Release ACS Nano 2010, 2, 1033-1041
37. Bhattacharya, R.; Mukherjee, P. Biological properties of "naked" metal nanoparticles Adv. Drug Delivery 2008, 60, 1289-306
38. Connor, E. E.; Mwamuka, J.; Gole, A.; Murphy, C. J.; Wyatt, M. D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity Small 2005, 1, 325-7
39. O'Shaughnessy, J. A. Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer Clin. Breast Cancer 2003, 4, 318-328
40. Peer, D.; Karp, J. M.; Hong, S.; Farokhazad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2007, 2, 751-760
41. Symon, Z.; Peyser, A.; Tzemach, D. Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes Cancer 1999, 86, 72-78
42. Perez, A. T.; Domenech, G. H.; Frankel, C.; Vogel, C. L. Pegylated Liposomal Doxorubicin (Doxil®) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience Cancer Invest. 2002, 20, 22-29
43. Schmidinger, M.; Wenzel, C. Locker, G. J. Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma Br. J. Cancer 2001, 85, 1850-1852
44. Wollina, U.; Dummer, R.; Brockmeyer, N. H. Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma Cancer 2003, 98, 993-1001
45. Skubitz, K. M. Phase II trial of pegylated-liposomal doxorubicin (Doxil) in sarcoma Cancer Invest. 2003, 21, 167-176
46. Harrington, K. J.; Lewanski, C.; Northcote, A. D. Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck Eur. J. Cancer 2001, 37, 2015-2022
47. Johnston, S. R.; Gore, M. E. Caelyx(R) - phase II studies in ovarian cancer Eur. J. Cancer 2001, 37, 8-14
48. Wang, F.; Wang, Y. C.; Dou, S.; Xiong, M. H.; Sun, T. M.; Wang, J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells ACS Nano 2011, 5 (5) 3679-3692
49. Kievit, F. M.; Wang, F. Y.; Fang, Ch.; Mok, H.; Wang, K.; Silber, J. R.; Ellenbogen, R. G.; Zhang, M. Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro J. Controlled Release 2011, 152, 76-83
50. 4 nanoparticle core and a PEG-functionalized porous silica shell Chem. Commun. 2010, 46, 8633-8635
51. Xu, X.; Persson, H. L.; Richardson, D. R. Molecular Pharmacology of the Interaction of Anthracyclines with Iron Mol. Pharmacol. 2005, 68, 261-271
52. Massart, R. Preparation of Aqueous Magnetic Liquids in Alkaline and Acidic Media IEEE Trans. Magn. 1981, MAG-17, 1247-1248
53. Salgueiriño-Maceira, V.; Correa-Duarte, M. A.; Farle, M.; López-Quintela, A.; Sieradzki, K.; Diaz, R. Bifunctional Gold-Coated Magnetic Silica Spheres Chem. Mater. 2006, 18, 2701-2706
54. Stöber, W.; Fink, A.; Bohr, E. Controlled growth of monodisperse silica spheres in the micron size range J. Colliod Interface Sci. 1968, 26, 62-69
55. Enüstün, B. V.; Turkevich, J. Coagulation of Colloidal Gold J. Am. Chem. Soc. 1963, 85 (21) 3317-3328
56. Schneider, G.; Decher, G. From Functional Core/Shell Nanoparticles Prepared via Layer-by-Layer Deposition to Empty Nanospheres Nano Lett. 2004, 4, 1833-1839
57. O'Brien, R. W.; White, L. R. Electrophoretic Mobility of a Spherical Colloidal Particle J. Chem. Soc., Faraday Trans. 1978, 274, 1607-1624
58. 3 Particles with Different Axial (Length/Width) Ratios J. Solid State Chem. 1994, 108, 158-163
59. 3 J. Solid State Chem. 1983, 49, 325-333
60. 3: Synchrotron X-ray Powder Diffraction and High-Resolution Electron Microscopy Studies J. Appl. Crystallogr. 1995, 28, 141-145
61. Wells, A. F. Structural Inorganic Chemistry; Oxford Univ. Press: London, 1975.
62. Haas, C. Phase transitions in crystals with the spinel structure J. Phys. Chem. Solids 1965, 26, 1225-1226
63. Mikhaylova, M.; Jo, Y. S.; Kim, D. K.; Bobrysheva, N.; Andersson, Y.; Eriksson, T.; Osmolowsky, M.; Semenov, V.; Muhammed, M. The Effect of Biocompatible Coating Layers on Magnetic Properties of Superparamagnetic Iron Oxide Nanoparticles Hyperfine Interact. 2004, 156-157, 257-263
64. Martinez, L.; Leinen, D.; Martín, F.; Gabas, M.; Ramos-Barrado, J. R.; Quagliata, E.; Dalchiele, E. A. Electrochemical growth of diverse iron oxide (Fe3O4, a-FeOOH, and c-FeOOH) thin films by electrodeposition chemical tuning J. Electrochem. Soc. 2007, 154 (3) D126-D133
65. Koleva, D. A.; Guo, Z.; van Breugel, K.; de Wit, J. H. W. The beneficial secondary effects of conventional and pulse cathodic protection for reinforced concrete, evidenced by X-ray and microscopic analysis of the steel surface and the steel/cement paste interface Mater. Corros. 2009, 60 (9) 704-715
66. Grosvenor, A. P.; Kobe, B. A.; Biesinger, M. C.; McIntyre, N. S. Investigation of multiplet splitting of Fe 2p XPS spectra and bonding in iron compounds Surf. Interface Anal. 2004, 36, 1564-1574
67. Temesghen, W.; Sherwood, P. M. A. Analytical utility of valence band X-ray photoelectron spectroscopy of iron and its oxides, with spectral interpretation by cluster and band structure calculations Anal. Bioanal. Chem. 2002, 373, 601-608
68. Caruso, F.; Lichtenfeld, H.; Donath, E.; Möhwald, H. Investigation of Electrostatic Interactions in Polyelectrolyte Multilayer Films: Binding of Anionic Fluorescent Probes to Layers Assembled onto Colloids Macromolecules 1999, 32, 2317-2328
69. Oshima, H. In Interfacial Electrokinetics and Electrophoresis; Delgado, A. V., Ed.; Dekker: New York, 2002; p 123.
70. Brust, M.; Bethell, D.; Kiely, C. J.; Schiffrin, D. J. Self-Assembled Gold Nanoparticle Thin Films with Nonmetalic Optical and Electronic Properties Langmuir 1998, 14, 5425-5429
71. Mayya, K. S.; Schoeler, B.; Caruso, F. Preparation and Organization of Nanoscale Polyelectrolyte-Coated Gold Nanoparticles Adv. Funct. Mater. 2003, 13 (3) 183-188
72. Caruso, F.; Spasova, M.; Salgueirino-Maceira, V.; Liz-Marzan, L. M. Multilayer Assemblies of Silica-Encapsulated Gold Nanoparticles on Decomposable Colloid Templates Adv. Mater. 2001, 13, 1090-1095
73. Salgueirino-Maceira, V.; Caruso, F.; Liz-Marzan, L. M. Coated Colloids with Tailored Optical Properties J. Phys. Chem. B 2003, 107, 10990-10994
74. Lowery, T. Nanomaterials for the life sciences; Wiley-VCH: Weinheim, 2009; pp 3-54.
75. Prijic, S.; Sersa, G. Magnetic nanoparticles as targeted delivery systems in oncology Radiol. Oncol. 2011, 45 (1) 1-16
76. 4 (M = Fe, Co, Mn) Nanoparticles J. Am. Chem. Soc. 2004, 126, 273-279
77. 3 Particles J. Appl. Phys. 1968, 39, 1261-1263
78. Millan, A.; Urtizberea, A.; Silva, N. J. O.; Palacio, F.; Amaral, V. S.; Snoeck, E.; Serin, V. Surface effects in maghemite nanoparticles J. Magn. Mater. 2007, 312, L5-L9
79. 4 nanoparticles from ferric salt and characterization of the size-dependent superparamagnetic properties Pure Appl. Chem. 2000, 72 (1-2) 37-45
80. 2H) functionalized ferrimagnetic iron oxide nanoparticles for potential bio-applications J. Mater. Chem. 2004, 14, 2781-2786
81. 3 Eur. Phys. J. B 2000, 14, 681-689
82. 4 Nanoparticles Phys. Rev. Lett. 1996, 77, 394-397
83. Feltin, N.; Pileni, M. P. New Technique for Synthesizing Iron Ferrite Magnetic Nanosized Particles Langmuir 1997, 13, 3927-3933
84. Liao, M. H.; Chen, D. H. Preparation and characterization of a novel magnetic nano-adsorbent J. Mater. Chem. 2002, 12, 3654-3659
85. Jezzard, P.; Matthews, P. M.; Smith, S. M. Functional MRI: an introduction to methods; Oxford University Press: Oxford, 2002.
86. Kuperman, V. Magnetic resonance imaging: physical principles and applications; Academic Press: San Diego, 2000.
87. Park, Y. I.; Piao, Y.; Lee, N.; Yoo, B.; Kim, B. H.; Hongchoi, S.; Hyeon, T. Transformation of hydrophobic iron oxide nanoparticles to hydrophilic and biocompatible maghemite monocristals for use as highly efficient MRI contrast agents J. Mater. Chem. 2011, 21, 11472-11477
88. Mirza, A. Z.; Shamshad, H. Preparation and characterization of doxorubicin functionalized gold nanoparticles Eur. J. Med. Chem. 2011, 46, 1857-1860
89. Mahmud, A.; Xiong, X. B.; Lavasanifar, A. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery Eur. J. Pharm. Biopharm. 2008, 69, 923-934
90. del Rosario, L. S.; Demirdirek, B.; Harmon, A.; Orban, D.; Uhrich, K. E. Micellar Nanocarriers Assembled from Doxorubicin-Conjugated Amphiphilic Macromolecules (DOX-AM) Macromol. Biosci. 2010, 10, 415-423